Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

US0327973006
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG000C9K8K4
AVXL
Anavex Life Sciences Corp
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Biotechnology · THEMEFOLIO: $HLTH
NAME
Anavex Life Sciences Corp
ISIN
US0327973006
TICKER
AVXL
MIC
XNAS
REUTERS
AVXL.OQ
BLOOMBERG
AVXL US
Do., 15.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 15, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. (NASDAQ: AVXL) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged vi...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Do., 15.10.2026       Anavex Life Sciences
US0327973006

NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Do., 15.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 14, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in t...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Do., 15.10.2026       Anavex Life Sciences
US0327973006

If you have suffered a loss on your Anavex Life Sciences Corp. (“Anavex” or the “Company”) (NASDAQ: AVXL) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost. Investors have unti...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Mi., 14.10.2026       Anavex Life Sciences
US0327973006

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Anavex To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Anavex between November 26, 2025 and August 28, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Mi., 14.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 14, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL) on behalf of investors that purchased or otherwise acquired Anavex securities between November 26, 2025 and August 28, 2026 (the...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Mi., 14.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 13, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in t...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Di., 13.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 12, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in t...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Mo., 12.10.2026       Anavex Life Sciences
US0327973006

LOS ANGELES, Oct. 12, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Anavex Life Sciences Corp.IF YOU SUFFERED A LOSS ON YOUR ANAVEX LIFE SCIENCES CORP. INVESTMENTS, CLICK HERE BEFORE NOVEMBER 30, 2026 (LEAD PLAINTIFF DEADLINE...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Mo., 12.10.2026       Anavex Life Sciences
US0327973006

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Anavex To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Anavex between November 26, 2025 and August 28, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Mo., 12.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 12, 2026) -  Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL) on behalf of investors that purchased or otherwise acquired Anavex securities between November 26, 2025 and August 28, 2026...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Mo., 12.10.2026       Anavex Life Sciences
US0327973006

NEW YORK, Oct. 12, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Anavex Life Sciences Corp. ("Anavex" or "the Company") (NASDAQ: AVXL) for for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Shareh...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Mo., 12.10.2026       Anavex Life Sciences
US0327973006

LOS ANGELES, Oct. 12, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Anavex Life Sciences Corp. ("Anavex" or "the Company") (NASDAQ: AVXL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promul...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
So., 11.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 11, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in the se...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Sa., 10.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 10, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in t...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Sa., 10.10.2026       Anavex Life Sciences
US0327973006

NEW YORK, Oct. 10, 2026 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in the securities class acti...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Sa., 10.10.2026       Anavex Life Sciences
US0327973006

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Anavex To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Anavex between November 26, 2025 and August 28, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Fr., 09.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 9, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in th...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Do., 08.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in th...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Do., 08.10.2026       Anavex Life Sciences
US0327973006

LOS ANGELES, Oct. 8, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Anavex Life Sciences Corp. (AVXL) have opportunity to lead the securities fraud class action lawsuit.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ANAVEX LIFE SCIENCES CORP. (AVXL), CLICK HERE BEFORE NOVEMBER 30, 2026 (THE LEAD...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Do., 08.10.2026       Anavex Life Sciences
US0327973006

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming November 30, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Anavex Life Sciences Corp. (“Anavex” or the “Company”) (NASDAQ: AVXL) securities between November 26, 2025 and August 28, 2026 inclus...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Do., 08.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 8, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. (NASDAQ: AVXL) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged vio...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Do., 08.10.2026       Anavex Life Sciences
US0327973006

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Anavex To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Anavex between November 26, 2025 and August 28, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Do., 08.10.2026       Anavex Life Sciences
US0327973006

The Red Flags: What Insiders Allegedly Knew Before Shareholders Did. Anavex now says its Board reviews and executive certifications could operate on incomplete information, and it has told investors to rely only on its revised clinical trial descriptions.NEW YORK  , Oct. 8, 2026 /PRNewswire/ -- SueWallSt announces that a securities class action has...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Do., 08.10.2026       Anavex Life Sciences
US0327973006

NEW YORK, Oct. 8, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Do., 08.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 8, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL) on behalf of investors that purchased or otherwise acquired Anavex securities between November 26, 2025 and August 28, 2026 (the "...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Mi., 07.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 7, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"). A class actio...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Mi., 07.10.2026       Anavex Life Sciences
US0327973006

Law Offices of Howard G. Smith reminds investors of the upcoming November 30, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Anavex Life Sciences Corp. (“Anavex” or the “Company”) (NASDAQ: AVXL) securities between November 26, 2025 and August 28, 2026, inclusive (the “Class Period”).IF YOU ARE A...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Mi., 07.10.2026       Anavex Life Sciences
US0327973006

Key Dates and Disclosure Events Shareholders Need to Know. The lawsuit claims Anavex called its controls effective for months before a for-cause CEO termination, a late filing, and amended reports allegedly exposed a material weakness.NEW YORK, Oct. 7, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP encourages investors who suffered losses in Anavex...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Di., 06.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 6, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL) on behalf of investors that purchased or otherwise acquired Anavex securities between November 26, 2025 and August 28, 2026 (the "...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Di., 06.10.2026       Anavex Life Sciences
US0327973006

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Anavex To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Anavex between November 26, 2025 and August 28, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Di., 06.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 6, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"). A class actio...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Di., 06.10.2026       Anavex Life Sciences
US0327973006

The Law Offices of Frank R. Cruz reminds investors of the upcoming November 30, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Anavex Life Sciences Corp. (“Anavex” or the “Company”) (NASDAQ: AVXL) securities between November 26, 2025 and August 28, 2026, inclus...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Di., 06.10.2026       Anavex Life Sciences
US0327973006

NEW YORK, Oct. 5, 2026 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"). A class action lawsuit has already be...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Mo., 05.10.2026       Anavex Life Sciences
US0327973006

NEW YORK, Oct. 5, 2026 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. (NASDAQ: AVXL) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations of the fed...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Mo., 05.10.2026       Anavex Life Sciences
US0327973006

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise Anavex Life Sciences Corp. (“Anavex” or the “Company”) (NASDAQ: AVXL) securities between November 26, 2025 and August 28, 2026, inclusive (the...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Mo., 05.10.2026       Anavex Life Sciences
US0327973006

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Anavex Life Sciences Corp. (“Anavex” or the “Company”) (NASDAQ: AVXL) common stock between November 26, 2025 and August 28, 2026, inclusive (the “Class Period”). Anavex Life Sciences Corp. investors have until November 30, 2026 t...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Mo., 05.10.2026       Anavex Life Sciences
US0327973006

LOS ANGELES, Oct. 5, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Anavex Life Sciences Corp. ("Anavex" or "the Company") (NASDAQ: AVXL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulg...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Mo., 05.10.2026       Anavex Life Sciences
US0327973006

NEW YORK, Oct. 5, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Anavex Life Sciences Corp. ("Anavex" or "the Company") (NASDAQ: AVXL) for for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Shareho...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
So., 04.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 4, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"). A class actio...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
So., 04.10.2026       Anavex Life Sciences
US0327973006

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Anavex To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Anavex between November 26, 2025 and August 28, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Sa., 03.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 3, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"). A class actio...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Sa., 03.10.2026       Anavex Life Sciences
US0327973006

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Anavex To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Anavex between November 26, 2025 and August 28, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Fr., 02.10.2026       Anavex Life Sciences
US0327973006

SAN DIEGO, Oct. 2, 2026 /PRNewswire/ -- Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons and entities who purchased or otherwise acquired Anavex Life Sciences Corp. (NASDAQ: AVXL) securities between November 26, 2025 and August 28, 2026, inclusive (the "Class Period"). Anavex describes its...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Fr., 02.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"). A class actio...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Do., 01.10.2026       Anavex Life Sciences
US0327973006

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased or otherwise acquired Anavex Life Sciences Corp. (“Anavex” or the “Company”) (NASDAQ: AVXL) common stock between November 26, 2025 and August 28, 2026, inclusive (the “Class Period”). Anavex Life Sciences Corp. investors hav...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Do., 01.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 1, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. (NASDAQ: AVXL) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged vio...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Do., 01.10.2026       Anavex Life Sciences
US0327973006

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf Anavex Life Sciences Corp. (“Anavex” or the “Company”) (NASDAQ: AVXL) investors concerning the Company’s possible violations of the federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON A...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Do., 01.10.2026       Anavex Life Sciences
US0327973006

NEW YORK, Oct. 1, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink
Do., 01.10.2026       Anavex Life Sciences
US0327973006

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Anavex To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Anavex between November 26, 2025 and August 28, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Zur Nachricht
Anavex Life Sciences
Charts & Research Termsheets Terminal
Permalink